1. health and fitness
2. disease

E komo mai kakou! Welcome everyone!
The American Society of Clinical Laboratory Science (ASCLS) Hawaii and Clinical
Laboratory Management Association (CLMA) Aloha welcomes you to the 2015
Hawaii Clinical Laboratory Conference and Exhibits. This will be held at the
Honolulu Country Club near Salt Lake, convenient to many Honolulu medical
facilities.
Our volunteers from the planning committee have prepared an outstanding program
with nationally recognized speakers as well as local experts ready to share their
expertise. There will be many exhibitors ready to demonstrate and share the latest
in the clinical laboratory, tasty refreshments, and a chance to catch up with your
colleagues past and present.
Please express your appreciation to our sponsors, vendors, our local laboratories
and employers who make this annual meeting possible. Thank you also to the
volunteers who started planning this conference months ago.
These committee
members deserve a sincere and heartfelt MAHALO.
Registration: Gale Fujitani (Kaiser), Jennifer Baba (DLS)
Facilities: Lynne Ramirez (Tripler, retired), Larry Shima (Kaiser)
Exhibits: Eben Chun (PAC/RIM), Kristen Croom (Queen’s)
PACE Coordinator and Finance: Linda Sakuda (Tripler)
Program: Chairperson Ryan Tsuji (Kuakini), Sheri Gon (UH – MT Program),
Glenda Pangelinan (CLH), Skip Keane (DLS, retired), Kent Kitagawa (DOH), Claire
Muranaka (DLS), Susan Naka (DOH), Reyn Nakayama (DLS), Lynne Ramirez
(Tripler, retired), Susan Taura (DLS)
Website: Leslynne Perry (DLS), Rayna Hirata (Queen’s)
The success of this conference depends on your support and participation.
Plan on meeting and greeting the board members of ASCLS Hawaii and CLMA
Aloha Chapter. They will be present throughout the conference, and would be
happy to “talk story” and hear from you. See you there!
Aloha no,
Marcella Yee
President, ASCLS Hawaii
Garan Ito
President, CLMA Aloha Chapter
1
2015 HAWAII CLINICAL LABORATORY
CONFERENCE & EXHIBITS
GENERAL INFORMATION
Website www.HiClinLabConference.org
Registration
Lunch
Exhibits
ASCLS Business Meeting
Heavy Pupus will be served.
Come for information on
upcoming ASCLS events
Registration Desk, located in the lobby of the Honolulu Country Club
Wednesday, April 15, 2015
7:30 a.m. – 10:00 a.m.
11:30 a.m. – 4:00 p.m.
Thursday, April 16, 2015
7:30 a.m. – 10:00 a.m.
11:30 a.m. – 4:00 p.m.
Wednesday, April 15, 2015
11:30 a.m. – 1:30 p.m.
Thursday, April 16, 2015
11:30 a.m. – 1:30 p.m.
Main Dining Room
Wednesday, April 15, 2015
11:30 a.m. – 5:00 p.m.
Thursday, April 16, 2015
11:30 a.m. – 3:30 p.m.
Wednesday, April 15, 2015
2
5:30 p.m. – 7:00 p.m.
#
TITLE
Conference Session Tracks
TRACK
LEVEL
Blood Bank
SPEAKER
DAY
TIME
20
Blood Product Safety
BB
Interm
Dr. Randal Covin
THU
8:00-9:30
24
Blood Product Utilization Management
BB
Interm
Dr. Randal Covin
THU
10:00-11:30
2
Early Intervention for Chronic Diseases:
Prognostic Markers to Improve Quality of
Life
CHEM
Interm
Dr. Ramani. Wonderling
WED
8:00-9:30
4
NT-proBNP: Analytical and Clinical
Considerations for Improving Patient Care
CHEM
Basic
Dr. Robert Fitzgerald and
Dr. Lori Daniels
WED
8:00-9:30
5
The Endocrinology of Aging: Is there a
Fountain of Youth?
CHEM
Interm
Dr. David Schaffner
WED
10:00-11:30
Basic
D Matsuda/Cathy
Matsuoka/Dr. Kobayashi
THU
3:30-5:00
HEME
Interm
Dr. David Schaffner
WED
8:00-9:30
HEME
Interm
Donald Wright
WED
10:00-11:30
HEME
Interm
Barbara Burch
THU
1:30-3:00
IMMUNO
Basic
Carl Schroder
WED
1:30-3:00
IMMUNO
Basic
Carl Schroder
WED
3:30-5:00
IMMUNO
Interm
Chanin McClurkin
THU
8:00-9:30
Chemistry
General
29
CSI Honolulu – An Introduction to
Forensic Science
GEN
Hematology
1
6
25
Differential diagnosis of Left Shift
An Overview of Automated Hematology
Analyzers
Hematology Scatter Plot Interpretation –
Keys to Seeing the Big Picture
Immunology
15
The ABC's of APS: How the clinical
laboratory plays a role in diagnosis and
monitoring of Antiphospholipid Syndrome
Advances in auto-immune testing for the
laboratory: Discuss new assays that help
clarify and identify auto-immune
syndromes
19
Specific IgE Testing for Primary Care
10
3
4
Workshop #1 Intermediate
Subject Area – Hematology
Wednesday, April 15
8:00 – 9:30 am
1.5 Contact Hours
Differential Diagnosis of Left Shift
David F. Schaffner Ph.D., MT(ASCP)
Medical Affairs Manager
Beckman Coulter, Inc.
Brea, California
Sponsored by Beckman Coulter
While left shift is a very common abnormality seen by labs during CBC testing, its significance can vary
significantly, ranging from a simple and localized infection to life threatening conditions such as acute promyelocytic leukemia. In this presentation we will review differential diagnosis for various clinical conditions
associated with left shift, and discuss the proper procedures laboratories can implement to make sure that the
most critical diseases that can lead to left shift are not missed.
Objectives:
1. Discriminate the stages in the maturation of granulocytes
2. Discuss possible clinical conditions associated with Left Shift, and the features you can use upon
smear review to confirm their diagnosis.
3. Describe good laboratory practices to minimize the risks of one of these diagnosis being missed.
4. Identify novel approaches for quantifying left shift and understanding the true clinical relevance of
these measurements.
Workshop #2 Intermediate
Subject Area – Chemistry
Wednesday, April 15
8:00 – 9:30 am
1.5 Contact Hours
Early Intervention for Chronic Diseases: Prognostic Markers to Improve Quality
of Life
Ramani Wonderling , PhD
Scientific Affairs Manager
Abbott Diagnostics
Abbott Park, Illinois
Sponsored by Abbott Diagnostics
Chronic conditions such as diabetes and cardiovascular disease are major health care burdens. Diabetes
significantly increases the risk for cardiovascular disease. Therefore, early detection and monitoring of
diabetes results in decreased morbidity and mortality. Current guidelines recommend using HbA1c for the
early diagnosis and monitoring of diabetes mellitus to curb the growing epidemic. In addition, the use of high
sensitivity troponin-I for early rule-in/rule-out of myocardial infarction is recommended by recent ESC
guidelines. Heart failure is often an outcome of MI. The use of galectin-3 and high sensitivity troponin-I
could have prognostic value for chronic heart failure and acute coronary syndrome.
Objectives:
1. Explain the clinical utility of HbA1c for diagnosis and monitoring of diabetes
2. Describe the advantage of High Sensitivity Troponin-I in the acute setting
3. Describe the prognostic use of Galectin-3 and High Sensitivity Troponin-I in heart failure and acute
coronary syndrome
Workshop #3 Basic
Subject Area – Safety
Wednesday, April 15
5
8:00 – 9:30 am
1.5 Contact Hours
General Infection Control and Ebola/Measles Response
Les Chock SM, SLS
Infection Control Coordinator
Kaiser Permanente
Honolulu, Hawaii
Sponsored by Kaiser Permanente
The Laboratory is an important partner with Infection Control. Infection Preventionists act upon diagnostic
testing results to ensure that proper CDC Transmission Based Precautions are utilized for the safety of
patients, their families and the medical staff. These include Standard, Contact, Droplet and Airborne
Isolation. Participants will learn what type of precautions the CDC recommends for the various infectious
diseases. In addition the Infection Control Guidelines for an Ebola Virus Disease (EVD) patient will be
covered. Finally a real life situation covering an actual response to a Measles patient on Maui will be
presented.
Objectives:
1. List the 4 CDC Transmission Based Precautions for Infection Control
2. Classify the diseases in each of the 4 CDC Precautions
3. Describe the CDC Infection Control Guidelines for a suspected EVD (Ebola) patient.
4. Discuss the Infection Control response to a measles patient.
Workshop #4 Basic
Subject Area – Chemistry
Wednesday, April 15
8:00 – 9:30 am
1.5 Contact Hours
NT-proBNP: Analytical and Clinical Consideration for Improving Patient Care
Robert Fitzgerald, Ph.D.
Professor of Pathology
University of California-San Diego
San Diego, California
Sponsored by Roche Diagnostics
Dr. Lori Daniels
Professor of Pathology
University of California-San Diego
San Diego, California
Through extensive research, NT-proBNP has shown to be a powerful indicator in the evaluation of heart
failure. Dr. Fitzgerald and Dr. Daniels of UC San Diego will discuss analytical metrics to use when choosing
assays for your hospital. Additionally, they will discuss how NT-proBNP can be used to supplement your
judgment in the management of heart failure patients in a clinical setting.
Objectives:
1. Describe the stability of BNP and NT-proBNP under various storage conditions.
2. Describe the effect of age, body mass, and renal function on concentrations of BNP and NT-proBNP.
3. Apply appropriate cutoffs of natriuretic peptides in the diagnosis and treatment of heart failure.
4. Utilize natriuretic peptides to monitor acute and chronic heart failure patients.
Workshop #5 Intermediate
Subject Area – Chemistry
Wednesday, April 15
10:00 – 11:30 am 1.5 Contact Hours
Endocrinology of Aging – Is there a Fountain of Youth?
David F. Schaffner Ph.D., MT(ASCP)
Medical Affairs Manager
Beckman Coulter, Inc.
Brea, California
Sponsored by Beckman Coulter
6
This presentation discusses the aging process and the human endocrine systems involved. Emphasis will be
placed on the Thyroid, Adrenal, Pituitary and Reproductive systems. The clinical laboratory and its
collaborative role in the management of the aging patient will be highlighted. Finally, the specific health
issues in the aging female and male will be discussed along with palliative measures to help combat the
effects of the aging process. Is there a “Fountain of Youth”? No not really, but we can manage how well we
age.
Objectives:
1. List three contributors to the aging process
2. Briefly describe the changes in these systems with age: adrenal, pituitary, thyroid, reproductive.
3. Describe the hormones frequently measured in the assessment of the aging endocrine systems.
Workshop #6 Intermediate
Subject Area – Hematology
Wednesday, April 15
10:00 – 11:30 am
1.5 Contact Hours
An Overview of Automated Hematology Analyzers
Donald R. Wright MT(ASCP)
Scientific Affairs Manager
Abbott Laboratories
Santa Clara, California
Sponsored by Abbott Laboratories
Automated Hematology Analyzers continue to transform the hematology laboratory with new technological
developments while expanding the amount of information and subsequently improving disease detection.
Hematology analyzers count cells and measure various characteristics of the cells counted. The cell counters
are able to classify and count different cell types including the five sub-classes of mature white blood cells, as
well as the traditional complete blood count (CBC) thus minimizing the need for microscopic review of the
blood smear except for those samples flagged as abnormal. Commercial analyzers are available from
multiple manufacturers offering a wide variety of technology and methods. This session will discuss the
general principles of instrument technology and methods, and considerations of limitations including
interferences and flagging.
Objectives:
1. Describe electronic impedance technology in cell counting and differentiation by automated
hematology analyzers.
2. Describe light scatter technology using a minimum of two angles of detection and the principle of
hydrodynamic focusing and laminar flow.
3. List two sources of interfering substances that affect WBC counting.
4. List two sources of interfering substances that affect platelet counting.
Workshop #7 Basic
Subject Area – Management
Wednesday, April 15
10:00 – 11:30 am
1.5 Contact Hours
Feedback is a Gift: Giving and Receiving Feedback
Cynthia Kitagawa, BBA
President
Insight Consulting and Training, LLC
Honolulu, Hawaii
Sponsored by Insight Consulting and Training, LLC
Feedback is an honest, nonjudgmental, and personal response to another person’s communications or
behaviors. When delivered properly, feedback is a gift to help the receiver learn how their behaviors are
perceived by others and gain insight to how they can improve their skills and/or strengthen relationships.
7
How we give and receive the feedback determines whether or not it truly is a gift to the recipient. In this
session you will learn techniques to effectively receive and give feedback to enhance performance.
Objectives:
1. Describe the Johari Window Interpersonal Awareness Model.
2. Describe the 3 Feedback Triggers.
3. Recognize techniques to receive and give feedback more effectively
Workshop #8 Basic
Subject Area – Microbiology
Wednesday, April 15
10:00 – 11:30 am
1.5 Contact Hours
Inside Microbiology of Hospital Associated Infections: Screening Approaches for
MRSA and Clostridium difficile
Sarah L. Moseley
Lead Scientific Affairs Manager
Roche Diagnostics Corporation
Pembroke Pines, Florida
Sponsored by Roche Diagnostics
MRSA is a methicillin-resistant Staphylococcus aureus, a staph bacteria that is resistant to many antibiotics.
In a healthcare setting, infection with MRSA can cause severe problems such as bloodstream infections and
surgical site infection posing risk to patient health and increased burden on healthcare costs. Clostridium
difficile, or C.diff.is a difficult to treat HAI that remains at historically high incidence levels in the United
States. C. difficile causes diarrhea linked to approx. 14,000 American deaths each year. During this
workshop we will discuss the challenging disease states and epidemiology of these two prevalent HAIs,
common approaches to screening and surveillance and new approaches to treatment and prevention. We will
discuss new PCR based assays designed to be incorporated into screening strategies for these difficult to treat
HAIs.
Objectives:
1. Describe the meaning of the term Hospital Associated Infections (HAIs) and explain the disease
states and epidemiology of two prevalent HAI infections, MRSA and C. diff.
2. Discuss the importance of HAI screening programs as they relate to MRSA and C.diff. infections and
describe current guidelines with respect to these HAIs.
3. Discuss the design and intended use of 2 new PCR based assays for the screening of MRSA and C.
diff.
4. Diagram the challenges faced for future treatment and eradication of the HAIs MRSA and C.diff.
Workshop #9 Basic
Subject Area - Management
Wednesday, April 15
1:30 – 3:00 pm
1.5 Contact Hours
Hiring, Training, Retraining Entry Level Lab Personnel
Ken Curtis BS, PBT(ASCP)
Technical Supervisor – Client Response and Communication Team
ARUP Laboratories
Salt Lake City, Utah
Sponsored by ARUP Laboratories
Entry positions in the laboratory are crucial to quality testing. Unfortunately, many positions such as
phlebotomists, technicians, and processors are the first to turnover in the laboratory. This session will cover
best practices in hiring quality personnel, training them to succeed, and strategies for retaining them. This
session will include case studies from two different laboratories who were able to successfully reduce
turnover and improve quality in entry level lab personnel.
8
Objectives:
1. Identify obstacles in retaining entry level laboratory positions
2. Understand best practices in hiring appropriate personnel
3. Recognize strategies for improving training of entry level personnel
4. Recognize strategies for retaining entry level laboratory personnel
Workshop #10 Basic
Subject Area – Immunology
Wednesday, April 15
1:30 – 3:00 pm
1.5 Contact Hours
The ABC's of APS: How the clinical laboratory plays a role in diagnosis and
monitoring of Antiphospholipid Syndrome
Carl Schroder MT(ASCP)
Manager, IFA Technical Sales
Inova Diagnostics, Inc.
San Diego, California
Sponsored by Inova Diagnostics
Anti-Phospholipid Syndrome is an auto-immune coagulopathy causing stroke, myocardial infarction, deep
vein (or artery) thrombosis or recurrent pregnancy lose. It is diagnosed most commonly in women, but also
affects men. There is no cure, but early diagnosis and with close monitoring it can be managed. We will look
at the disease diagnosis, symptoms and treatments as well as how old, new and emerging assays help the
physician with his diagnosis and treatment.
Objectives:
1. Explain APS, the clinical signs, symptoms, treatments and laboratory testing used to help the
physician in his diagnosis.
2. Discuss the current criteria for testing
3. Review the history of APS and the development of laboratory testing.
4. Discuss the new markers and identification of ‘sero-negative’ patients highlighting the benefits of
PS/PT and savings to the patient.
Workshop #11 Basic
Subject Area – Management
Wednesday, April 15
1:30 – 3:00 pm
1.5 Contact Hours
CLSI QMS20 Understanding the Cost of Quality in the Laboratory
Luann Ochs, MS
Sr. Vice President, Operations
Clinical and Laboratory Standards Institute (CLSI)
Wayne, Pennsylvania
Sponsored by Clinical Laboratories of Hawaii, LLP
Every laboratory wants to produce high quality test results at the lowest possible cost. The challenge is to
spend appropriately to ensure good quality, while eliminating the costs associated with poor quality. In this
session, attendees will learn the differences between types of quality costs, and learn basic tools to quantify
the costs of poor quality and failures. Identifying the poor quality costs can enable laboratories to focus
resources on preventing, rather than reacting to failures.
Objectives:
1. List, describe, and provide laboratory examples of quality costs
2. Compare between costs that support good quality and those that result from poor quality
3. Apply basic tools to quantify laboratory failure costs
4. Review preventive actions to eliminate high cost potential failures
9
Workshop #12 Intermediate
Subject Area – Microbiology
Wednesday, April 15
1:30 – 3:00 pm
1.5 Contact Hours
Tropical Infectious Diseases Research in Hawaii, with focus on flaviviruses
specifically dengue and West Nile viruses
Vivek Nerurkar, Ph.D.
Professor and Chair, Department of Tropical Medicine, Medical Microbiology and Pharmacology
University of Hawaii
Honolulu, Hawaii
Sponsored by American Society for Microbiology Hawaii Branch
Research conducted in the Department of Tropical Medicine, Medical Microbiology and Pharmacology at the
University of Hawaii on the pathogenesis of tropical diseases, particularly flavivirus infections such as
dengue and West Nile virus, will be discussed. In addition, research and development of vaccines and
diagnostic reagents and laboratory tests for these diseases will also be introduced.
Objectives:
1. List some of the tropical diseases for which research is currently being conducted in Hawaii.
2. Briefly explain the pathogenesis of dengue and West Nile viruses.
3. Describe some of the vaccines for the prevention of these diseases currently under development in
Hawaii.
4. Describe the development of diagnostic reagents and laboratory tests for some of these infections.
Workshop #13 Basic
Subject Area – General
Wednesday, April 15
3:30 – 5:00 pm
1.5 Contact Hours
Point of Care Testing in Hawaii –2015 What’s Old is New
Blane Nagareda MT(ASCP)
Point of Care Coordinator
Kaiser Permanente
Honolulu, Hawaii
Sponsored by Kaiser Permanente
Technology has evolved from giant analyzers to hand held devices; testing at the patient’s side – Point of
Care Testing. Testing personnel are no longer trained in laboratory medicine. This workshop is an open
forum discussing the challenging world of Point of Care Testing especially recent changes in regulatory
requirements. Active participation will be expected from all participants.
Objectives:
1. Identify POCT challenges.
2. Discuss a successful outcome.
3. Discuss new regulations.
4. Identify resources and contacts for support.
Workshop #14 Basic
Subject Area – General
Wednesday, April 15
3:30 – 5:00 pm
1.5 Contact Hours
Avoiding Specimen Collection Errors that Can Lead to Erroneous Results
Ken Curtis BS, PBT(ASCP)
Technical Supervisor – Client Response and Communication Team
10
ARUP Laboratories
Salt Lake City, Utah
Sponsored by ARUP Laboratories
Errors in specimen collection result in inaccurate results. This presentation focuses on identifying specimen
collection issues and strategies for preventing them. We will discuss common errors in patient identification,
phlebotomy techniques, and specimen labeling. We will also discuss identifying collection issues via preanalytical processes, training for accuracy in collection, and monitoring improvement.
Objectives:
1. Recognize the most common specimen collection issues
2. Recognize the ways these collection issues impact testing
3. Identify ways to implement processes to improve quality of specimen collection
Workshop #15 Basic
Subject Area – Immunology
Wednesday, April 15
3:30 – 5:00 pm
1.5 Contact Hours
Advances in auto-immune testing for the laboratory: Discuss new assays that
help clarify and identify auto-immune syndromes.
Carl Schroder MT(ASCP)
Manager, IFA Technical Sales
Inova Diagnostics, Inc.
San Diego, California
Sponsored by Inova Diagnostics
Auto-immune diseases have come to the forefront in medicine in the past 15 to 20 years. Diseases that were
considered to be idiopathic in the past, today are being recognized as caused by our own bodies immune
responses to various stimuli. Although there aren’t cures for auto-immune diseases, many can be managed
with new and old medications once they are properly identified. With the introduction of new assays, the
identification and diagnosis of many can be cut from years to months or even days for a diagnosis and
because of better sensitivity and specificity of the assays, the diagnosis is often more accurate. We will
discuss several of these new assays and how they can be used by the physician in his diagnosis and treatment
of his patient.
Objectives:
1. Discuss IBD vs IBS, growing numbers of those presenting to the doctor and the role of new assays
used in differentiating and diagnosing.
2. Explain the new ESPGHAN guidelines for celiac diagnosis. Advances in testing that introduce a new
era for enhanced diagnosis that can avoid many biopsies in the pediatric patient.
3. Discuss new assays used on patients with positive ANA to exclude many normal (no systemic
disease) people from those with systemic auto-immune diseases. Saves the patient psychological
trauma and expenses.
4. Discuss other future markers and their proposed role.
Workshop #16 Intermediate
Subject Area – Safety
Wednesday, April 15
CLSI M29 Protection of Laboratory Workers
Luann Ochs, MS
Sr. Vice President, Operations
Clinical and Laboratory Standards Institute (CLSI)
Wayne, Pennsylvania
Sponsored by Clinical Laboratories of Hawaii, LLP
11
3:30 – 5:00 pm
1.5 Contact Hours
In our current environment of increasingly antibiotic-resistant organisms, it is essential that we keep our
laboratory workers safe from laboratory-acquired infections. The recently updated CLSI document M29-A4,
Protection of Laboratory Works from Occupationally Acquired Infections, provides the latest thinking on best
practices to prevent workers from exposure, and minimizing transfer of infectious organisms outside of the
laboratory. Attendees will learn the current best practices including the use of standard precautions, good
laboratory practices, safety devices, personal protective equipment, and appropriate decontamination and
disposal of biological hazards. Focus is also on safe transport, equipment hazards, incident response, planning
for public health emergencies, biological risk assessment, and best practices for biosafety training and
competency assessment.
Objectives:
1. Explain the latest recommendations for standard precautions and use of safety equipment.
2. Discuss biological risk assessment and risk mitigation.
3. List best practices for laboratory equipment risks, including cleaning and decontamination
4. Describe how to prepare for public health emergencies
5. Outline a biosafety training program and assess biosafety competency
Workshop #17 Intermediate
Subject Area – Molecular
Diagnostics
Thursday, April 16
8:00 – 9:30 am
1.5 Contact Hours
Dueling Banjos: ILI Technologies Go head-to-Head
Remedios Gose
Biological Response Section Supervisor
State Laboratories Division
Honolulu, Hawaii
Precilia Calimlim
Microbiologist
State Laboratories Division
Honolulu, Hawaii
Roland Yee
Chief of Virology
State Laboratories Division
Honolulu, Hawaii
Although Hawaii has year-round influenza activity, peak influenza season is relatively predictable occurring
after holiday travel in the months of January through March. Periodic point prevalence studies conducted by
Hawaii State Laboratories (HSL) has shown that various respiratory viruses are responsible for influenza-like
illness (ILI) in Hawaii, and up to 25% of the specimen sample sets have multiple viruses. This session will
present an analysis of findings from the clinical specimens submitted for Flu testing during the peak influenza
season (2013-2014). The testing technology utilized by HSL has uncovered respiratory pathogens cocirculating with Influenza viruses. This technology may be a cost-effective alternative to labor-intensive
traditional culture methods.
Objectives:
1. Identify the number and type of respiratory pathogens detected by the ViiA™7 platform from three
hundred (300) randomized specimens submitted for Flu testing during 2013-2014 peak influenza
season in Hawaii.
2. Describe the demographic distribution of clinical samples that were submitted during the Hawaii
Influenza peak season in 2013-2014.
3. Evaluate the performance of the TaqMan Array Card (TAC) controls (IPCO, GADPH, and RNP) on
clinical samples.
Workshop # 18 Basic
Subject Area – Management
Thursday, April 16
8:00 – 9:30 am
Skills to Work With & Motivate the Next Generation
James McVey
Supervisor – Institute for Learning
ARUP Laboratories
12
1.5 Contact Hours
Salt Lake City, Utah
Sponsored by ARUP Laboratories
Generation WHY? The Millennial generation, also known as Generation Y, is defined by work-life balance,
multi-tasking, and an integration of technology in all parts of life. Millennial employees are motivated by
relationships, and thus benefit from being managed differently than other generations. This presentation will
focus on millennial employees’ strengths, motives and values. What drives millennial employees and how can
employers tap into their strengths? How can employers effectively communicate with and manage millennial
employees while guiding millennials’ to do their very best?
Objectives:
1. Identify and describe the Millennial generation, including Millennials’ values, motivations and
strengths.
2. Explain types of supportive behaviors and communication methods that can be used to engage and
motivate next generation employees.
3. Describe and list methods for managing Millennial employees in the most effective way possible.
Workshop #19 Intermediate
Subject Area – Immunology
Thursday, April 16
8:00 – 9:30 am
1.5 Contact Hours
Specific IgE Testing for Primary Care
Chanin McClurkin RN, MSN, ARNP
Nurse Practitioner and Clinical Educator
Thermo Fisher Scientific
Salt Lake City, Utah
Sponsored by ThermoFisher Scientific
The incidence of allergic disease, including asthma, is rising at an alarming rate in the United States. The
majority of allergic patients are managed by primary care clinicians. To treat allergy, pharmacotherapy is
used. To prevent allergic symptoms (including asthma exacerbations) allergic triggers must be objectively
identified by specific IgE testing. This session will elucidate allergy diagnosis and treatment from a primary
care clinician’s point of view.
Objectives:
1. Differentiate currently available platforms for serologic specific IgE testing
2. Explain why specific IgE testing is critical for the management of allergic patients
3. Recognize the application of new, cutting-edge IgE testing platforms
Workshop #20 Intermediate
Subject Area – Blood Bank
Thursday, April 16
8:00 – 9:30 am
1.5 Contact Hours
Blood Product Safety
Dr. Randal Covin, MD
Interim Medical Director
Blood Bank of Hawaii
Honolulu, Hawaii
Sponsored by Blood Bank of Hawaii
Blood product transfusion is as safe as it’s ever been. However, like all medical procedures there is the
potential for adverse reactions. In order to make transfusion as safe as possible, blood safety measures are
present throughout the entire process of transfusion – from vein-to-vein. This session will cover these blood
safety measures from the time a unit of blood is donated to the time that unit is transfused. In addition, the
current infectious and non-infectious risks of transfusion will be presented.
13
Objectives:
1. Summarize the role of regulating and accrediting agencies in promoting blood transfusion safety.
2. Describe the limitations of donor screening tests and the methods blood centers use to maintain blood
product safety.
3. Recognize the current risks to recipients associated with blood transfusion.
Workshop #21 Basic
Subject Area –Safety
Thursday, April 16
10:00 – 11:30 am
1.5 Contact Hours
General Infection Control and Ebola/Measles Response
Les Chock SM, SLS
Infection Control Coordinator
Kaiser Permanente
Honolulu, Hawaii
Sponsored by Kaiser Permanente
***This workshop is a repeat of Workshop #3***
Workshop #22 Basic
Subject Area - Management
Thursday, April 16
10:00 – 11:30
am
1.5 Contact Hours
Communicating Hard Things
James McVey
Supervisor – Institute for Learning
ARUP Laboratories
Salt Lake City, Utah
Sponsored by ARUP Laboratories
When the topic of communicating hard things is brought up, it is often thought of negatively. Why? If having
a hard conversation will benefit the employee, a department or a relationship, why do we avoid them? What is
the risk of not having that difficult conversation? This presentation will focus on useful methods and actions
which can be used in a laboratory setting or in personal circumstances to effectively prepare for, and
successfully accomplish difficult conversations.
Objectives:
1. Explain methods to prepare for hard conversations.
2. Explain why difficult conversations are avoided and describe actions to take so that avoidance is
overruled.
3. Describe the approach and proper use of language so that difficult conversations are executed
effectively.
Workshop #23 Intermediate
Subject Area – Management
Thursday, April 16
10:00 – 11:30
am
1.5 Contact Hours
CLSI EP23 Laboratory Quality Control Based on Risk Management
Luann Ochs, MS
Sr. Vice President, Operations
Clinical and Laboratory Standards Institute (CLSI)
Wayne, Pennsylvania
Sponsored by Diagnostic Laboratory Services, Inc.
14
Equivalent quality control (EQC) is going away on January 1, 2016, replaced by individualized quality
control plans (IQCPs). Will your laboratory be ready? This is a major change for laboratory testing, and it
impacts almost every section of the lab. In this session we will review the new CMS/CLIA requirements and
how they apply to your laboratory tests; we will understand what is meant by “the right QC”; we will review
the concept of risk management and mitigation, and we will see some examples of how it is applied to create
IQCPs.
Objectives:
1. Describe the CMS/CLIA requirements for Individualized Quality Control Plans (IQCP), effective
1/1/2016
2. Explain the CMS/CLIA documentation requirements for IQCPs
3. Discuss risk management and how to apply it to laboratory tests
4. Explain how to determine which risks require actions to mitigate them
5. Describe how to create an IQCP
Workshop #24 Intermediate
Subject Area – Blood Bank
Thursday, April 16
10:00 – 11:30 am 1.5 Contact Hours
Blood Product Utilization Management
Dr. Randal Covin, MD
Interim Medical Director
Blood Bank of Hawaii
Honolulu, Hawaii
Sponsored by Blood Bank of Hawaii
Blood transfusion is the single most commonly performed procedure during inpatient visits. Blood
transfusion practice shows evidence of significant variation and The Joint Commission and the American
Medical Association included blood transfusion as one of five medical interventions discussed during their
National Summit on Overuse. In order to provide patients with the safest and best quality medical care, blood
products must be transfused appropriately. This session will cover patient blood management – an evidencebased, multidisciplinary approach to managing patients who might need transfusion. In addition, the
indications for blood product transfusion will be reviewed as well as the indications for blood product
modification (e.g. washing, irradiation).
Objectives:
1. Define patient blood management.
2. Cite the major drivers of patient blood management.
3. Recognize the indications for transfusion of the commonly transfused blood components (red cells,
plasma, platelets, and cryoprecipitate).
4. Recognize the indications for common modification of blood components (e.g. washing and
irradiation).
Workshop #25 Intermediate
Subject Area – Hematology
Thursday, April 16
1:30 – 3:00 pm
1.5 Contact Hours
Hematology Scatter Plot Interpretation – Keys to Seeing the Big Picture
Barbara Burch, MT(ASCP)
Memorial Sloan Kettering Cancer Center
New York, New York
Sponsored by Sysmex
15
Practiced hematology scatter-plot interpretation can enable laboratories to deliver reliable results to clinicians
in a timely manner, thus facilitating improved patient care. This session will use case studies to show how
such interpretation improved the care of patients in a New York cancer center. Keys to learning how
laboratories can tease information out of their instruments will be discussed.
Objectives:
1. Describe how the Complete Blood Count results are used in the care of oncology patients.
2. Explain how practiced scatter-plot interpretation improves oncology patient care while providing
timely and reliable results to the clinician.
3. Identify 3 keys to begin more advanced hematology scatter-plot interpretation.
Workshop #26 Intermediate
Subject Area – Management
Thursday, April 16
1:30 – 3:00 pm
1.5 Contact Hours
CLSI’s New Tools for Laboratories Developing LDTs (Laboratory Developed
Tests)
Luann Ochs, MS
Sr. Vice President, Operations
Clinical and Laboratory Standards Institute (CLSI)
Wayne, Pennsylvania
Sponsored by Diagnostic Laboratory Services, Inc.
As everyone is now aware, FDA intends to regulate laboratory developed tests just like manufactured tests. In
this session we will first look at the announced FDA requirements, and then look at tools that CLSI has
available for helping a laboratory meet FDA’s requirements. The tools will encompass test development and
validation and test implementation. In addition, we will look at FDA’s quality system requirements, and touch
on how these requirements are different from CLIA.
Objectives:
1. Explain the proposed FDA requirements for laboratory developed tests
2. Explain how FDA’s Quality System Requirements apply to laboratory developed tests
3. List the included elements for FDA’s Quality System Requirements for Laboratory Developed Tests
4. List best practices for meeting FDA’s Quality System Requirements for Laboratory Developed Tests
Workshop #27 Intermediate
Subject Area – Chemistry
Thursday, April 16
1:30 – 3:00 pm
1.5 Contact Hours
Synthetic Cannabinoids and Designer Drug Trends
Carl Linden
Manager of Toxicology
Diagnostic Laboratory Services
Honolulu, Hawaii
Sponsored by Diagnostic Laboratory Services, Inc.
Drug use and abuse is as old as Mankind. In an effort to avoid detection and prosecution, there is an ongoing
“cat and mouse game”, between the substance abusers and the laboratories, to find new mood-altering
compounds that are unscheduled and undetectable. The scores of synthetic cannabinoids such as Spice and
K2 are at the forefront of the current substance abuse landscape. This session will cover the history,
physiological effects, detection, and prevalence of the synthetic cannabinoids as well as summarizing some of
the lesser known designer drugs.
Objectives:
1. Summarize the technical and legal history of the synthetic cannabinoids.
16
2. Describe the physiological effects of synthetic cannabinoid abuse.
3. Define the detection methodologies for synthetic cannabinoids and other new designer drugs.
4. Outline the prevalence of synthetic cannabinoids abuse in the United States.
Workshop #28 Intermediate
Subject Area – Microbiology
Thursday, April 16
1:30 – 3:00 pm
1.5 Contact Hours
Development of an Ebola vaccine and diagnostic reagents for detection of Ebola
exposure
Axel Lehrer, Ph.D.
Assistant Professor
University of Hawaii, Department of Tropical Medicine, Medical Microbiology and Pharmacology
Honolulu, Hawaii
Sponsored by the American Society for Microbiology, Hawaii Branch
Ebola virus disease is a highly infectious disease with a very high mortality rate. There are currently no FDAapproved preventive or therapeutic countermeasures available for this disease. The development of an Ebola
virus vaccine candidate for the prevention of disease will be described. This vaccine consists of nonreplicating (non-infectious) soluble viral subunits (viral proteins). In addition, the vaccine components can be
used for the development of therapeutic measures, such as specific antibodies, as well as for the development
of diagnostic laboratory reagents allowing specific and sensitive detection of Ebola virus exposure in human
patients.
Objectives:
1. Describe the components of an Ebola virus subunit vaccine.
2. Describe how this vaccine differs from other Ebola vaccine candidates.
3. Explain how this vaccine could be used for the development of therapeutic as well as preventive
measures.
4. Describe how the vaccine components could be applied to the development of specific diagnostic
reagents.
Workshop #29 Basic
Subject Area – General
Thursday, April 16
3:30 – 5:00 pm
1.5 Contact Hours
CSI Honolulu – An Introduction to Forensic Science
Doryn Matsuda
Cathy Matsuoka
Evidence Specialist
Supervisor
City & County of Honolulu
City & County of Honolulu
Honolulu, Hawaii
Honolulu, Hawaii
Sponsored by the Honolulu Police Department
Dr. Masahiko Kobayashi
Medical Examiner
City & County of Honolulu
Honolulu, Hawaii
Interest in forensic science has exploded over the past several years due to popular TV shows such
as “CSI” and “Hawaii 5-0”. Come and take a peek into the real world of the forensic scientist.
Members of the Honolulu Police Department’s Scientific Investigation Section and the Department
of the Medical Examiner will present real case examples to explain their roles in making Honolulu
the safest place to live, work, and play.
Objectives:
1. Describe the principles of crime scene investigation, death investigation, analysis of physical
evidence, and the interrelationship of all the components into a final product.
2. Explain what a forensic pathologist does to help determine cause of death to comfort family
and to assist in death investigations.
17
2015 HAWAII CLINICAL LABORATORY
CONFERENCE & EXHIBITS
Honolulu, Hawaii
Honolulu Country Club
Meeting Schedule
TIME
WEDNESDAY
April 15
THURSDAY
April 16
7:00 AM
Registration
7:30 a.m. – 10:00 a.m.
Registration
7:30 a.m. – 10:00 a.m.
8:00 AM
Workshops
8:00 a.m. – 9:30 a.m.
Workshops
8:00 a.m. – 9:30 a.m.
10:00 AM
Workshops
10:00 a.m.–11:30 a.m.
Workshops
10:00 a.m.–11:30 a.m.
11:00 AM
Registration
11:30 a.m. – 4:00 p.m.
Registration
11:30 a.m. – 4:00 p.m.
Lunch
11:30 a.m. – 1:30 p.m.
Lunch
11:30 a.m. – 1:30 p.m.
Exhibits
11:30 a.m. – 5:30 p.m.
Exhibits
11:30 a.m. – 3:30 p.m.
Workshops
1:30 p.m. – 3:00 p.m.
Workshops
1:30 p.m. – 3:00 p.m.
3:00 PM
Workshops
3:30 p.m. – 5:00 p.m.
Workshops
3:30 – 5:00 p.m..
4:00 PM
.
9:00 AM
12:00 PM
1:00 PM
2:00 PM
5:00 PM
5:30 PM
ASCLS Business Meeting
5:30 p.m. – 7:00 p.m.
18
2015 Hawaii Clinical Laboratory Conference and Exhibits Registration Form
REGISTER ON-LINE at www.HiClinLabConference.org using the Registration link.
LAST NAME__________________________FIRST NAME______________________
ADDRESS______________________________________________________________
CITY_____________STATE____ZIP CODE___________HOME PHONE__________
EMPLOYER___________________BUS.PHONE_____________EMAIL___________
ASCLS/CLMA/ASM Membership No.__________________EXP. DATE__________
NOTE: Out of state members –please provide photocopy of current membership card
[Please circle]
Membership
Category
Member
Non
Member
Student/Retired
Member
Early Bird Rates (Deadline: Received by March 10, 2015)
Full Day Workshop
$80
$180
Half Day Workshop
60
160
$35
25
Regular Rates (Received March 10, 2015 to April 1, 2015)
Full Day Workshop
$ 100
$200
Half Day Workshop
80
180
$50
35
Please enroll me in the following workshop(s):
Wednesday April 15, 2015
8:00 – 9:30
Workshop #
10:00 – 11:30
Workshop #
Lunch (Circle one)
Yes No
8:00 – 9:30
Workshop #
10:00 – 11:30
Workshop #
Lunch (Circle one)
Yes No
1:30-3:00 pm
Workshop #
3:30-5:00 pm
Workshop #
$
Fees
3:30-5:00 pm
Workshop #
$
Thursday April 16, 2015
1:30-3:00 pm
Workshop #
Total
$
Form of Payment:
 Check made payable to University of Hawai’i (enclose copy of completed form)
 I hereby authorize University of Hawai’i the use of my credit card account:
____Visa ____MasterCard
____Discover
Credit Card No: ___________________________ Exp. Date (Mo/Yr.) _________
Signature: _________________________________________________________
 Institution Code: ______
UHCC15-07
19
REGISTRATION INFORMATION
REGISTRANT CATEGORIES:
MEMBER is a current member of good standing of the American Society for Clinical Laboratory Science (ASCLS), the
Clinical Laboratory Management Association (CLMA), or American Society for Microbiology (ASM)
STUDENT MEMBER is any person who is engaged at least half time in a recognized program leading to either an
Associate or Bachelor degree in Clinical Laboratory Science (Medical Technology) or one who is in a recognized Clinical
Laboratory internship program.
NON MEMBERS are encouraged to join ASCLS, CLMA, or ASM and qualify for the member rate registration fee.
On-Line application forms can be found at www.ascls.org or www.clma.org or www.asm.org.
REGISTRATION NOTES:
Priority will be given to online registrants for workshops.
Availability of workshops after the early bird deadline is not guaranteed.
Most workshop fees include registration and lunch.
Half Day workshop fee may be applied to workshop(s) totaling up to 3 contact hours on the
same day.
Full Day workshop fee may be applied to workshops totaling over 3 contact hours on the
same day.
Lunch will be included for those registered for Half Day or Full Day workshops only.
No charge to attend exhibits.
FEES: Registration fees vary according to the number of workshops you plan to attend. Please indicate on the program
registration form the proper registration fee for your level of participation. Full payment must accompany all registrations.
Credit card numbers submitted with registration will be processed upon receipt. Returned checks will incur additional fees.
Please complete the registration form on-line at www.HiClinLabConference.org using the Registration link. Payments are
acceptable by credit card on-line or by mailed with the printed registration form to the address below. Checks made payable
to: University of Hawai’i.
UH Conference and Event Services
Attn: Kenlynn Nelson
1951 East-West Road, #202
Honolulu, HI 96822
DEADLINES: Early Bird Registration must be received by March 10, 2015. Full registration rates will apply after the
early bird deadline. Regular Rates: Due by April 1, 2015. On-Site registration will also be available, but workshops and
lunch cannot be guaranteed.
REFUNDS: Requests for refunds must be received at the UH Conference and Event Services by April 1, 2015 in writing.
No refunds will be made thereafter. Refunds will be done in the same manner payment was made. Please allow
approximately six to eight weeks for processing.
CONTINUING EDUCATION: ASCLS-Hawaii is an approved provider of continuing education programs in clinical
laboratory science through the ASCLS P.A.C.E® Program. The listed courses are approved for CA licensed clinical
laboratory scientists and personnel.
PARKING: Complimentary
HANDOUTS: Registrants will be responsible for downloading their handouts from the website
www.HiClinLabConference.org. Registration confirmation notice will include username/password.
ACCESSIBILITY ASSISTANCE: If you require assistance due to mobility, hearing, or sight impairment, you are
encouraged to contact the UH Conference and Event Services at 956-8204 by March 15, 2015.
Please direct all registration inquiries to: UH Conference and Event Services
808 956-8204 [phone]; 808 956-4372 [fax]
kenlynn8@hawaii.edu
20
EXHIBITS
The CLMA – Aloha Chapter invites the clinical laboratory community to come and visit the Exhibits
area in the Main Dining Room of the Honolulu Country Club. Admission is free. View displays showing the
latest instrumentation and products for clinical laboratories. Exhibits will once again be the highlight of the
Hawaii Clinical Laboratory Conference & Exhibits. Plan to visit the exhibits. The exhibit hours are
convenient. Stick around when your morning workshop is done or come early before the afternoon
presentations. Door prizes will be announced throughout the exhibit hours on both days and pupus will be
served as well.
You may have noticed corporate sponsorship designated for most of the workshops. Seek out those
sponsoring companies on the exhibition floor and thank the representatives. Let them know you appreciate
their support of the 2015 Hawaii Clinical Laboratory Conference & Exhibits and look forward to seeing them
again the next year. This is a list of 2014 exhibitors. We expect these exhibitors and others to participate.
Abbott Diagnostics - POC
Abbott Diagnostics
Abbott Diagnostics - Molecular
Advanced Instruments
Alere
Alpha-Tec
ARUP
ASCLS Hawaii
Audit Microcontrols, Inc.
Beckman Coulter
Beckman Coulter Primary Care Division
Becton Dickinson
BioMerieux
Bio-Rad
College of American Pathology
Cardinal Health
Cepheid
CLMA Aloha Chapter
Diagnostica Stago
Fisher Healthcare
Genmark Diagnostics
Gen-Probe
Grifols USA LLC
Hologic Inc.
Immucor Gamma
Instrumentation Laboratory
Life Technologies (Thermo Fisher)
Opti Medical Systems
PAC/RIM Medical Technology & Supplies
Qiagen
Quest Diagnostics
Quidel (part of Diagnostic Hybrids)
Roche Diagnostics Molecular
Roche Diagnostics Blood gas
Sebia
Siemens Diagnostic Healthcare
Sysmex
Telcor
ThermoFisher Scientific
University of Washington
21
Directions to
Honolulu Country Club
Diamond Head (East) Bound from Ewa
1) Drive on Highway 78 towards Pearlridge and Aiea.
2) Take Exit #2: Moanalua Valley/Salt Lake/Red Hill.
3) Proceed up the hill and come to the three-way stop.
4) Go straight and proceed down the hill to another three-way stop.
5) Turn right onto Ala Napunani Street.
6) Go straight and take your first right, which will be Ala Hahanui Street.
7) Follow the road until you reach the three-way stop.
8) Turn right on Ala Puumalu Street.
9) Honolulu Country Club is located at 1690 Ala Puumalu Street at the end of the road.
22
Directions to
Honolulu Country Club
Ewa (West) Bound from Honolulu
1) Take H1 West to H201 towards Fort Shafter and Aiea, which becomes Highway 78.
2) Take Exit #2: Moanalua Valley/Salt Lake/Red Hill.
3) Take the immediate right on Puuloa Rd, that sign will read Moanalua Valley/Salt Lake.
4) Take an immediate left, that sign will read Salt Lake.
5) After turning left, merge into the right lane. You are now on Ala Napunani Street.
6) You will come to a three-way stop. Go straight.
6) Take the next right, which will be Ala Hahanui Street.
7) Follow the road until you reach the three-way stop.
8) Turn right on Ala Puumalu Street.
9) Honolulu Country Club is located at 1690 Ala Puumalu Street at the end of the road
23